Sayed S. Daoud

943 total citations
38 papers, 771 citations indexed

About

Sayed S. Daoud is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Sayed S. Daoud has authored 38 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 15 papers in Oncology and 8 papers in Epidemiology. Recurrent topics in Sayed S. Daoud's work include Cancer-related Molecular Pathways (10 papers), Cancer therapeutics and mechanisms (9 papers) and Liver Disease Diagnosis and Treatment (6 papers). Sayed S. Daoud is often cited by papers focused on Cancer-related Molecular Pathways (10 papers), Cancer therapeutics and mechanisms (9 papers) and Liver Disease Diagnosis and Treatment (6 papers). Sayed S. Daoud collaborates with scholars based in United States, Egypt and Canada. Sayed S. Daoud's co-authors include R. L. Juliano, Safia Wasi, Matthew M. Yeh, Dustin E. Bosch, Abdur Rehman, Yves Pommier, Beppino C. Giovanella, Kyunghee Lee, James E. Bruce and Xiaoting Tang and has published in prestigious journals such as Cancer Research, Advanced Drug Delivery Reviews and Biochemical and Biophysical Research Communications.

In The Last Decade

Sayed S. Daoud

38 papers receiving 749 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sayed S. Daoud United States	17	459	294	108	94	63	38	771
Essam Ghazaly United Kingdom	15	421 0.9×	274 0.9×	81 0.8×	178 1.9×	50 0.8×	62	904
Franca Maria Tuccillo Italy	14	547 1.2×	172 0.6×	169 1.6×	176 1.9×	24 0.4×	36	963
Tami Annable United States	17	571 1.2×	459 1.6×	95 0.9×	130 1.4×	20 0.3×	23	1.0k
Patricia Thompson United States	8	363 0.8×	359 1.2×	65 0.6×	85 0.9×	19 0.3×	21	850
Delores Mowles Canada	15	517 1.1×	636 2.2×	149 1.4×	116 1.2×	67 1.1×	22	1.4k
Li-Yuan Bai Taiwan	17	466 1.0×	150 0.5×	109 1.0×	99 1.1×	29 0.5×	42	869
Elizabeth Hopper-Borge United States	18	638 1.4×	954 3.2×	97 0.9×	132 1.4×	57 0.9×	20	1.5k
Marit Liland Sandvold Netherlands	15	462 1.0×	222 0.8×	68 0.6×	76 0.8×	96 1.5×	27	725
Abhisek Swaika United States	15	475 1.0×	549 1.9×	76 0.7×	145 1.5×	25 0.4×	30	1.1k

Countries citing papers authored by Sayed S. Daoud

Since Specialization

Citations

This map shows the geographic impact of Sayed S. Daoud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sayed S. Daoud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sayed S. Daoud more than expected).

Fields of papers citing papers by Sayed S. Daoud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sayed S. Daoud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sayed S. Daoud. The network helps show where Sayed S. Daoud may publish in the future.

Co-authorship network of co-authors of Sayed S. Daoud

This figure shows the co-authorship network connecting the top 25 collaborators of Sayed S. Daoud. A scholar is included among the top collaborators of Sayed S. Daoud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sayed S. Daoud. Sayed S. Daoud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yeh, Matthew M., Xiuhui Shi, Jingxuan Yang, et al.. (2022). Perturbation of Wnt/β‐catenin signaling and sexual dimorphism in non‐alcoholic fatty liver disease. Hepatology Research. 52(5). 433–448. 2 indexed citations

Dillon, Simon T., Manoj Bhasin, Xiaoxing Feng, David W. Koh, & Sayed S. Daoud. (2013). Quantitative proteomic analysis in HCV-induced HCC reveals sets of proteins with potential significance for racial disparity. Journal of Translational Medicine. 11(1). 239–239. 24 indexed citations

Zekri, Abdel‐Rahman N., et al.. (2013). Methylation of multiple genes in hepatitis C virus associated hepatocellular carcinoma. Journal of Advanced Research. 5(1). 27–40. 34 indexed citations

Zekri, Abdel‐Rahman N., Abeer A. Bahnassy, Mohamed M. Hafez, et al.. (2011). Characterization of chronic HCV infection-induced apoptosis. PubMed. 10(1). 4–4. 21 indexed citations

Wang, Tao, Kyunghee Lee, Abdur Rehman, Yves Pommier, & Sayed S. Daoud. (2006). PRIMA-1 induces apoptosis in p53 mutant breast cancer cell lines by inhibiting the JNK cell survival pathway and promoting the activation of proapoptotic p53 targets Bax and PUMA. Cancer Research. 66. 718–718. 2 indexed citations

Wang, Tao, Kyunghee Lee, Abdur Rehman, & Sayed S. Daoud. (2006). PRIMA-1 induces apoptosis by inhibiting JNK signaling but promoting the activation of Bax. Biochemical and Biophysical Research Communications. 352(1). 203–212. 31 indexed citations

Lee, Kyunghee, Tao Wang, Andrzej Paszczyński, & Sayed S. Daoud. (2006). Expression proteomics to p53 mutation reactivation with PRIMA-1 in breast cancer cells. Biochemical and Biophysical Research Communications. 349(3). 1117–1124. 14 indexed citations

Redkar, Alka, Gary G. Meadows, & Sayed S. Daoud. (2001). UCN-01 dose-dependent inhibition of normal hyperproliferative cells in mice. International Journal of Oncology. 19(1). 193–9. 3 indexed citations

Wasi, Safia, et al.. (2000). Enhancement of camptothecin-induced cytotoxicity with UCN-01 in breast cancer cells: abrogation of S/G 2 arrest. Cancer Chemotherapy and Pharmacology. 45(3). 252–258. 39 indexed citations

10.

Daoud, Sayed S., et al.. (1999). Antiangiogenic potential of camptothecin and topotecan. Cancer Chemotherapy and Pharmacology. 44(5). 411–416. 105 indexed citations

11.

Wasi, Safia, et al.. (1997). Sensitivity to camptothecin of human breast carcinoma and normal endothelial cells. Cancer Chemotherapy and Pharmacology. 40(6). 475–483. 30 indexed citations

12.

Wasi, Safia, et al.. (1996). Camptothecin exhibits selective cytotoxicity towards human breast carcinoma as compared to normal bovine endothelial cells in vitro. Anti-Cancer Drugs. 7(8). 851–857. 14 indexed citations

13.

Daoud, Sayed S., et al.. (1995). Antitumor effect of liposome-incorporated camptothecin in human malignant xenografts. Anti-Cancer Drugs. 6(1). 83–93. 39 indexed citations

14.

Daoud, Sayed S., et al.. (1995). Polymerase chain reaction analysis of cisplatininduced mitchondrial DNA damage in human ovarian carcinoma cells. Anti-Cancer Drugs. 6(3). 405–412. 8 indexed citations

15.

Daoud, Sayed S.. (1992). Cell membranes as targets for anti-cancer drug action. Anti-Cancer Drugs. 3(5). 443–454. 23 indexed citations

16.

Daoud, Sayed S., et al.. (1991). Synergistic cytotoxic actions of cisplatin and liposomal valinomycin on human ovarian carcinoma cells. Cancer Chemotherapy and Pharmacology. 28(5). 370–376. 8 indexed citations

17.

Juliano, R. L. & Sayed S. Daoud. (1990). Liposomes as a delivery system for membrane-active antitumor drugs. Journal of Controlled Release. 11(1-3). 225–232. 15 indexed citations

18.

Daoud, Sayed S., et al.. (1989). Liposomes in cancer therapy. Advanced Drug Delivery Reviews. 3(3). 405–418. 24 indexed citations

19.

Daoud, Sayed S. & R. L. Juliano. (1989). Modulation of doxorubicin resistance by valinomycin (NSC 122023) and liposomal valinomycin in Chinese hamster ovary cells.. PubMed. 49(10). 2661–7. 20 indexed citations

20.

Juliano, R. L., et al.. (1987). Membrane‐to‐Membrane Transfer of Lipophilic Drugs Used against Cancer or Infectious Diseasea. Annals of the New York Academy of Sciences. 507(1). 89–103. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact